ArticleThe oncologist2019

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Angela Lamarca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.